| Ranolazine prevents phenotype development in a mouse model of hypertrophic cardiomyopathy R Coppini, L Mazzoni, C Ferrantini, F Gentile, JM Pioner, A Laurino, ... Circulation: Heart Failure 10 (3), e003565, 2017 | 91 | 2017 |
| Pathogenesis of hypertrophic cardiomyopathy is mutation rather than disease specific: a comparison of the cardiac troponin T E163R and R92Q mouse models C Ferrantini, R Coppini, JM Pioner, F Gentile, B Tosi, L Mazzoni, B Scellini, ... Journal of the American Heart Association 6 (7), e005407, 2017 | 70 | 2017 |
| Kynurenic acid and zaprinast induce analgesia by modulating HCN channels through GPR35 activation F Resta, A Masi, M Sili, A Laurino, F Moroni, G Mannaioni Neuropharmacology 108, 136-143, 2016 | 65 | 2016 |
| Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy F Resta, L Micheli, A Laurino, V Spinelli, T Mello, L Sartiani, LDC Mannelli, ... Neuropharmacology 131, 403-413, 2018 | 62 | 2018 |
| Design, Synthesis, and Evaluation of Thyronamine Analogues as Novel Potent Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists G Chiellini, G Nesi, M Digiacomo, R Malvasi, S Espinoza, M Sabatini, ... Journal of Medicinal Chemistry 58 (12), 5096-5107, 2015 | 57 | 2015 |
| Body mass index and complications following major gastrointestinal surgery: a prospective, international cohort study and meta‐analysis EuroSurg Collaborative, R Blanco‐Colino, S Lee, SK Kamarajah, P Vasko, ... Colorectal Disease 20 (8), O215-O225, 2018 | 56 | 2018 |
| In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone … A Laurino, G De Siena, A Saba, G Chiellini, E Landucci, R Zucchi, ... European journal of pharmacology 761, 130-134, 2015 | 46 | 2015 |
| Selective blockade of HCN1/HCN2 channels as a potential pharmacological strategy against pain L Dini, M Del Lungo, F Resta, M Melchiorre, V Spinelli, ... Frontiers in Pharmacology 9, 1252, 2018 | 44 | 2018 |
| New insights into the potential roles of 3-iodothyronamine (T1AM) and newly developed thyronamine-like TAAR1 agonists in neuroprotection L Bellusci, A Laurino, M Sabatini, S Sestito, P Lenzi, L Raimondi, ... Frontiers in Pharmacology 8, 905, 2017 | 41 | 2017 |
| Dual-beam confocal light-sheet microscopy via flexible acousto-optic deflector V Gavryusev, G Sancataldo, P Ricci, A Montalbano, C Fornetto, L Turrini, ... Journal of biomedical optics 24 (10), 106504-106504, 2019 | 30 | 2019 |
| Pharmacological perspectives in sarcopenia: a potential role for renin-angiotensin system blockers? L Sartiani, V Spinelli, A Laurino, S Blescia, L Raimondi, E Cerbai Clinical Cases in Mineral and Bone Metabolism 12 (2), 135, 2015 | 30 | 2015 |
| Thyroid hormone, thyroid hormone metabolites and mast cells: a less explored issue E Landucci, A Laurino, L Cinci, M Gencarelli, L Raimondi Frontiers in cellular neuroscience 13, 79, 2019 | 29 | 2019 |
| 3D molecular phenotyping of cleared human brain tissues with light-sheet fluorescence microscopy L Pesce, M Scardigli, V Gavryusev, A Laurino, G Mazzamuto, N Brady, ... Communications Biology 5 (1), 447, 2022 | 27 | 2022 |
| 3-iodothyronamine (T1AM), a novel antagonist of muscarinic receptors A Laurino, R Matucci, G Vistoli, L Raimondi European Journal of Pharmacology 793, 35-42, 2016 | 25 | 2016 |
| Hit-to-lead optimization of mouse trace amine associated receptor 1 (mTAAR1) agonists with a diphenylmethane-scaffold: design, synthesis, and biological study G Chiellini, G Nesi, S Sestito, S Chiarugi, M Runfola, S Espinoza, ... Journal of Medicinal Chemistry 59 (21), 9825-9836, 2016 | 23 | 2016 |
| 3‐iodothyroacetic acid, a metabolite of thyroid hormone, induces itch and reduces threshold to noxious and to painful heat stimuli in mice A Laurino, G De Siena, F Resta, A Masi, C Musilli, R Zucchi, L Raimondi British journal of pharmacology 172 (7), 1859-1868, 2015 | 23 | 2015 |
| The pro-healing effect of exendin-4 on wounds produced by abrasion in normoglycemic mice S Bacci, A Laurino, ME Manni, E Landucci, C Musilli, G De Siena, ... European Journal of Pharmacology 764, 346-352, 2015 | 22 | 2015 |
| Large-scale, cell-resolution volumetric mapping allows layer-specific investigation of human brain cytoarchitecture I Costantini, G Mazzamuto, M Roffilli, A Laurino, FM Castelli, M Neri, ... Biomedical optics express 12 (6), 3684-3699, 2021 | 21 | 2021 |
| Anticonvulsant and neuroprotective effects of the thyroid hormone metabolite 3-iodothyroacetic acid A Laurino, E Landucci, F Resta, G De Siena, DE Pellegrini-Giampietro, ... Thyroid 28 (10), 1387-1397, 2018 | 20 | 2018 |
| Central effects of 3-iodothyronamine reveal a novel role for mitochondrial monoamine oxidases A Laurino, E Landucci, L Raimondi Frontiers in Endocrinology 9, 290, 2018 | 16 | 2018 |
Elisabetta CerbaiUniversità degli Studi di Firenze在 unifi.it 的电子邮件经过验证
